Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
Manatt HealthDecember 15, 2025

CMS GENEROUS Model Pricing Structure: What Medicaid Programs and Life Science Companies Need to Know

Manatt Health analyzes the new GENEROUS Model announced by CMS, comparing its pricing metrics to previously used most-favored-nation (MFN) approaches and outlining key design elements and timeline. The piece examines participation opportunities and risks for both pharmaceutical manufacturers and state Medicaid programs, addressing outstanding design questions that affect drug pricing and reimbursement in Medicaid managed care.

Pharmacy · Managed Care · Finance

Read the full analysis at Manatt Health →

This is outside commentary from Manatt Health, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Manatt Health

← Analysis & Perspectives

Get the daily briefing.